Tuesday, April 26, 2022

April 22, 2022 at 08:42PM NovoSeven

Product approval information is indicated for treatment of bleeding episodes and for the prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9m1EC0O

No comments:

Post a Comment